SCHEMBL22493897

SCHEMBL22493897

CC(C)(C)NCCc1cccc(OC(F)(F)F)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 1/20 0.38
CTSS P25774 2/20 0.35
CTSK P43235 2/20 0.35
KCNH2 Q12809 2/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
IDH1 O75874 3/20 0.34
IDH2 P48735 1/20 0.34
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
ADRB1 P08588 1/20 0.33
CHRM4 P08173 1/20 0.33
CYP4A11 Q02928 2/20 0.31
CYP4F2 P78329 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
TP53BP1 Q12888 1/20 0.31
PDCD1LG2 Q9BQ51 1/20 0.30
CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22481324 0.81 MAPK8 (0.46) TRPV3KCNH2HCRTR1HCRTR2PDCD1LG2
SCHEMBL22480852 0.79 TRPV3 (0.38) TRPV3CTSSCTSKKCNH2CTSL
SCHEMBL22493475 0.78 OPRM1 (0.36) KCNH2
SCHEMBL22493239 0.77 ADRB1 (0.41) CTSSCTSKKCNH2CTSLCTSB
SCHEMBL21849249 0.76 TRPV3 (0.38) TRPV3CTSSCTSKKCNH2IDH1
SCHEMBL17886911 0.74 SMN1; SMN2 (0.46) CTSSCTSKKCNH2CTSLCTSB
SCHEMBL22493399 0.73 CYP3A4 (0.36) CTSSCTSKKCNH2CTSLCTSB
SCHEMBL13680823 0.73 TRPV3 (0.34) TRPV3KCNH2IDH1IDH2HCRTR1
SCHEMBL30583867 0.73 TRPV3 (0.38) TRPV3IDH1IDH2HCRTR1HCRTR2
SCHEMBL22493448 0.72 APP (0.43) CTSSCTSKKCNH2CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2023225021-A1 COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) CURASEN THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed